Voncento
human coagulation factor VIII / human von willebrand factor
Hemophilia A
von Willebrand Diseases
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
EMEA-001037-PIP02-11-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0098/2019
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Factor VIII - referral
Article 31 referrals
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
EMEA-000312-PIP01-08-M07 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0274/2014
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Powder and solvent for solution for infusion
Decision date:
Last updated:
Compliance check: ✔
PIPHuman